1 May 2022 false No description of principal activity Taxfiler 2024.1 11930365business:PrivateLimitedCompanyLtd2022-05-012023-04-30 119303652022-04-30 119303652022-05-012023-04-30 11930365business:AuditExempt-NoAccountantsReport2022-05-012023-04-30 11930365business:FilletedAccounts2022-05-012023-04-30 119303652023-04-30 11930365business:Director12022-05-012023-04-30 11930365business:Director22022-05-012023-04-30 11930365business:Director32022-05-012023-04-30 11930365business:Director42022-05-012023-04-30 11930365business:RegisteredOffice2022-05-012023-04-30 119303652022-04-30 11930365core:WithinOneYear2023-04-30 11930365core:WithinOneYear2022-04-30 11930365core:ShareCapitalcore:PreviouslyStatedAmount2023-04-30 11930365core:ShareCapitalcore:PreviouslyStatedAmount2022-04-30 11930365core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-04-30 11930365core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-04-30 11930365core:PreviouslyStatedAmount2023-04-30 11930365core:PreviouslyStatedAmount2022-04-30 11930365business:SmallEntities2022-05-012023-04-30 11930365countries:EnglandWales2022-05-012023-04-30 11930365core:ComputerEquipment2022-05-012023-04-30 11930365core:ComputerEquipment2022-04-30 11930365core:ComputerEquipment2023-04-30 119303652021-05-012022-04-30 iso4217:GBP xbrli:pure
Company Registration No. 11930365 (England and Wales)
Sterling Pharma Limited Unaudited accounts for the year ended 30 April 2023
Sterling Pharma Limited Unaudited accounts Contents
Page
- 2 -
Sterling Pharma Limited Company Information for the year ended 30 April 2023
Directors
Mohammed Eshak Mohammed Ikhlaq Mohammed Adam Issat Asif Mahmood
Company Number
11930365 (England and Wales)
Registered Office
195-197 OTLEY ROAD BRADFORD WEST YORKSHIRE BD3 0JF UNITED KINGDOM
- 3 -
Sterling Pharma Limited Statement of financial position as at 30 April 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Tangible assets
2,102 
1,799 
Current assets
Inventories
11,303 
23,835 
Debtors
262 
279 
Cash at bank and in hand
19,205 
6,308 
30,770 
30,422 
Creditors: amounts falling due within one year
(50,267)
(47,601)
Net current liabilities
(19,497)
(17,179)
Net liabilities
(17,395)
(15,380)
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
(17,495)
(15,480)
Shareholders' funds
(17,395)
(15,380)
For the year ending 30 April 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 10 September 2023 and were signed on its behalf by
Mohammed Adam Issat Director Company Registration No. 11930365
- 4 -
Sterling Pharma Limited Notes to the Accounts for the year ended 30 April 2023
1
Statutory information
Sterling Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 11930365. The registered office is 195-197 OTLEY ROAD, BRADFORD, WEST YORKSHIRE, BD3 0JF, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
20% straight line
4
Tangible fixed assets
Computer equipment 
£ 
Cost or valuation
At cost 
At 1 May 2022
2,997 
Additions
1,128 
At 30 April 2023
4,125 
Depreciation
At 1 May 2022
1,198 
Charge for the year
825 
At 30 April 2023
2,023 
Net book value
At 30 April 2023
2,102 
At 30 April 2022
1,799 
5
Debtors
2023 
2022 
£ 
£ 
Amounts falling due within one year
Trade debtors
262 
262 
Other debtors
- 
17 
262 
279 
- 5 -
Sterling Pharma Limited Notes to the Accounts for the year ended 30 April 2023
6
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
VAT
76 
- 
Trade creditors
3,993 
- 
Other creditors
32,000 
32,000 
Loans from directors
13,423 
14,051 
Accruals
775 
1,550 
50,267 
47,601 
7
Average number of employees
During the year the average number of employees was 1 (2022: 1).
- 6 -